Gabapentin Solution
Product Images NDC 86211-112

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 86211-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jvet Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Oral Solution 1)

Formula (Gabapentin Oral Solution 1)
This text provides information on how to calculate Creatinine Clearance (CLCr) using the patient's age, weight, and serum creatinine levels. The formula to calculate CLCr is given, specifying adjustments for female patients. It includes the variables age in years, weight in kilograms, and serum creatinine in mg/dL.*
FDA Label Image

Structure (Gabapentin Oral Solution 2)

FDA Label Image

Diagram1 (Gabapentin Oral Solution 3)

Diagram1 (Gabapentin Oral Solution 3)
This text provides information about a study comparing mean pain scores for a placebo group and a group taking gabapentin at a dose of 3600 mg/day. The study is divided into a dose titration period of 4 weeks followed by a fixed dose period of 4 weeks. Data for the baseline and weeks 1 to 8 are shown in the chart.*
FDA Label Image

Diagram2 (Gabapentin Oral Solution 4)

Diagram2 (Gabapentin Oral Solution 4)
This is a description of a study related to pain management involving different doses of Gabapentin and a placebo. The study includes a 3-week dose titration period followed by a 7-week fixed dose period. Three groups are compared: placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The mean pain score at baseline and at different time points (1 week, 3 weeks, and 7 weeks) is assessed.*
FDA Label Image

Diagram3 (Gabapentin Oral Solution 5)

Diagram3 (Gabapentin Oral Solution 5)
This text appears to show percentages related to two studies, with asterisks denoting statistical significance levels. It also mentions three different amounts: GBP 3600, GBP 1800, and GBP 2400. The specific details or context of these percentages and amounts are not clear from this output.*
FDA Label Image

Diagram4 (Gabapentin Oral Solution 6)

FDA Label Image

Label (Label)

Label (Label)
This text contains information about an oral solution with a dosage of 250 mg per 5 mL, with a prescription-only status and NDC code 86211-112-01. It is advised to follow the prescribing information and keep the medication out of reach of children. The solution should be stored refrigerated at 2°C to 8°C. The manufacturer is Jvet Pharmaceuticals LLC based in Largo, FL. Pharmacies should dispense the medication guide separately to each patient. The total volume of the oral solution is 16 fl. oz. (470 mL).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.